First draft genome sequence of <i>Candidozyma auris</i> from a human clinical isolate in a major metropolitan hospital in Lima, Peru. [PDF]
Cuicapuza D +3 more
europepmc +1 more source
Relative contributions of the ERG11<sup>VF125AL</sup> and MRR1A<sup>N647T</sup> mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates. [PDF]
Barker KS +6 more
europepmc +1 more source
Antifungal Susceptibility and Resistance-Associated Gene Expression in Nosocomial <i>Candida</i> Isolates. [PDF]
Hernandez-Reyes FB +7 more
europepmc +1 more source
Early Signal Without Clinical Cases: A Single Clade III <i>Candidozyma auris</i> Isolate from a Face Mask Highlights the Value of Environmental Quality Control. [PDF]
Bauer A +6 more
europepmc +1 more source
Genomic epidemiology of Colombian resistant <i>Candida auris</i> isolates. [PDF]
Alvarado Casas ML +4 more
europepmc +1 more source
Genomic Insights of <i>Candida krusei</i>, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance. [PDF]
Jain K +5 more
europepmc +1 more source
Dual inhibition of ERG11 and CDR2 in drug-resistant Candida albicans by Indian phytochemicals: a combined in silico-in vitro approach. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source
Phenotypic and genomic characterization of azole resistance in Portuguese <i>Candida parapsilosis</i> isolates. [PDF]
Papuc AM +6 more
europepmc +1 more source
Emerging fluconazole-resistant <i>Candida parapsilosis</i> in Australia: a case cluster and insights into the genetic diversity of this species. [PDF]
Perera M +17 more
europepmc +1 more source

